"T1: isointense to the other facial muscles, or fatty infiltration in the inactive phase"
"T2/STIR: increased signal intensity may be seen due to the inflammatory process during the active phase, which normalises or becomes low signal during the inactive phase"
"T1 C+ (Gd): enhancement may be present in the active phase, not present in the inactive phase"
Expected headings
"Associations"
"proptosis/exophthalmos, with resultant periorbital oedema, chemosis and corneal dryness/ulceration"
"Although in many instances the disease activity plateaus in the inactive (stable or quiescent) phase 3,19, treatment is often required if there is diplopia, discomfort, any cosmetic issues, risk of corneal ulceration, and/or risk of optic nerve compression. Treatment during the initial active phase may reduce destructive sequela from inflammation 19."
"medical: supportive, selenium, glucocorticoids, rituximab, tocilizumab, teprotumumab, veligrotug"